Zipline, the global leader in instant logistics, Pfizer Inc. and BioNTech SE announced that Zipline has successfully completed the first long-range drone delivery of both authorized mRNA COVID-19 vaccines requiring ultra-cold-chain in Ghana.
The collaboration of the companies, which worked together earlier this year to develop and test an end-to-end vaccine delivery solution, will allow for the distribution of tens of thousands of doses of the Pfizer-BioNTech COVID-19 Vaccine in Ghana.
In addition to financial support for the pilot program, Pfizer and BioNTech provided technical assistance and know-how specific to the management and storage of the Pfizer-BioNTech COVID-19 Vaccine at -90°C to -60°C.
This partnership has paved the way for drone deliveries of mRNA vaccines, the firms said in a statement on Thursday.
Through the partnership, Pfizer, BioNTech and Zipline have brought together their expertise and capabilities to help advance more equitable vaccine distribution.
“Delivery to people in remote and hard-to-reach places is a primary challenge for global vaccination,” said Keller Rinaudo, co-founder and CEO of Zipline.
“In partnership with Pfizer and BioNTech, we have created a solution to address this potential pain point head on. Together, we are working to help transform vaccine distribution into a more effective, equitable process.”
Making COVID-19 vaccines accessible to an entire country’s populationpresents logistical challenges for many governments and healthcare organizations, particularly in low- and middle-income countries. Zipline is helping to address these challenges by implementing an end-to-end distribution model that safely delivers any COVID-19 vaccine to all corners of a country through its autonomous aircraft.
“Pfizer has a history of investing with partners to improve access to medicines and vaccines in the most remote areas of the world,” said Caroline Roan, Chief Sustainability Officer, Senior Vice President, Global Health and Social Impact, Pfizer Inc. “We are proud of this collaboration with Zipline to implement breakthrough solutions that help advance equitable access to COVID-19 vaccines, particularly for hard to reach and underserved populations.”
“The global distribution of COVID-19 vaccines requires a coordinated effort,” said [BioNTech representative]. “This collaboration between Pfizer, BioNTech and Zipline showcases our collective commitment to pioneering new solutions that can help address COVID-19 vaccine access challenges and help put an end to this pandemic.”
Olayinka Subair, Pfizer Cluster Lead, West Africa said, “Our focus is always on the patients as we deploy resources to bring treatments that extend and significantly improve their lives. We consistently seek to collaborate with stakeholders to support and expand access to reliable, affordable health care in communities all around.“
